Real-time enrollment status for this gastrointestinal stromal neoplasms clinical trial
Current Status
Recruiting
Checked: August 30, 2026 at 4:21 PM UTC
| NCT Number | NCT07585266 |
| Recruiting Status | Recruiting |
| Condition | Gastrointestinal Stromal Neoplasms |
| Phase | PHASE3 |
| Target Enrollment | 800 participants |
| Active Locations | 3 sites in the US |
| Sponsor | GlaxoSmithKline |
| Last Updated on CT.gov | August 19, 2026 (1 week ago) |
As of August 30, 2026: Clinical trial NCT07585266 is currently recruiting participants. This phase3 study for gastrointestinal stromal neoplasms is actively seeking new participants at 3 locations across the United States. The study is sponsored by GlaxoSmithKline. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07585266 is actively recruiting participants as of August 30, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07585266 was last updated 1 week ago (August 19, 2026). HelloStudys verifies this status automatically.